These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8035897)
21. [To treat effectively without delay. The data on fractures decisive]. MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873 [No Abstract] [Full Text] [Related]
22. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women. Bolanca S; Korsić M; Dekanić D; Cvijetić S Acta Med Croatica; 1998; 52(3):159-63. PubMed ID: 9818438 [TBL] [Abstract][Full Text] [Related]
25. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show]. Praxis (Bern 1994); 2004 Sep; 93(36):1454. PubMed ID: 15487859 [No Abstract] [Full Text] [Related]
26. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis. Thomas T; Lafage MH; Alexandre C J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168 [TBL] [Abstract][Full Text] [Related]
27. [To increase bone density faster and stronger]. MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589 [No Abstract] [Full Text] [Related]
28. Risedronate: a new bisphosphonate for the treatment of osteoporosis. Kessenich CR Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124 [No Abstract] [Full Text] [Related]
29. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Brown JP; Kendler DL; McClung MR; Emkey RD; Adachi JD; Bolognese MA; Li Z; Balske A; Lindsay R Calcif Tissue Int; 2002 Aug; 71(2):103-11. PubMed ID: 12085156 [TBL] [Abstract][Full Text] [Related]
31. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. Storm T; Kollerup G; Thamsborg G; Genant HK; Sørensen OH J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926 [TBL] [Abstract][Full Text] [Related]
32. [Etidronate versus alendronate]. Eriksen EF Tidsskr Nor Laegeforen; 1998 Feb; 118(6):949-50. PubMed ID: 9543818 [No Abstract] [Full Text] [Related]
33. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Cramer JA; Amonkar MM; Hebborn A; Altman R Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664 [TBL] [Abstract][Full Text] [Related]
34. [Correlation between studies and general practice]. MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791 [No Abstract] [Full Text] [Related]